Skip to main content
. 2022 Sep 8;13:986303. doi: 10.3389/fendo.2022.986303

Figure 1.

Figure 1

An overview of the metabolomics analysis workflow, and the inclusion and exclusion flowchart of the case-control study. * The sample collection and testing in untargeted metabolomics were conducted in our previous study. T2DM, type 2 diabetes mellitus; DR, diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy.